Thermo Fisher Scientific Inc. (TMO), Monsanto Company (MON): Billionaire Larry Robbins’ Top Picks Beat the Market Again in Q1

Next in line is the controversial agriculture company Monsanto Company (NYSE:MON), which is focused on providing high-yield seeds to farmers. Glenview held some 9.60 million shares valued at $1.15 billion. The company however pulled down the fund’s quarterly returns as it lost about 4.99% of its stock price during the quarter. After delivering financial results for the second quarter of fiscal year 2015 that came below guidance, the company’s management still believes it is on a path to more than double its current Earnings Per Share (EPS) by 2019. Among the billionaires that we track, 6 had investments totaling $1.69 billion in Monsanto Company (NYSE:MON) at the end of 2014. David Shaw of D E Shaw was one such investor, in addition Robbins.

The holding of Flextronics International Ltd. (FLEX) in Glenview’s portfolio stood at 75.13 million shares valued at $839.96 million. The company’s 13.42% quarterly returns were the highest among the above-mentioned top picks. Cliff Asness’ AQR Capital Management and Richard S. Pzena’s Pzena Investment Management are two other investment firms that profited from Flextronics’ price hike. Just yesterday Flextronics International Ltd. (FLEX) announced that it will partner with Sunedison Inc (NYSE:SUNE) to produce solar modules in Mexico that will be used in residential, utility and commercial projects in the U.S.

Glenview’s stake in Tenet Healthcare Corp (NYSE:THC) amounted to 13.81 million shares valued at $699.90 million. The healthcare company, which is part of Robbins’ bet on Obamacare depreciated by 2.29% over the first quarter. Donald Chiboucis’ Columbus Circle Investors held some 1.28 million shares of Tenet Healthcare Corp (NYSE:THC) valued at $65.03 million, according to the latest 13F filing.

Disclosure: None